Roy Cosan

Roy Cosan has a diverse work experience in various leadership positions. From 2013 to present, they have served as the President of Renova Therapeutics. Prior to that, from 2011 to present, they were the CEO of Metronom Health. From 2010 to 2013, they held the CEO position at Prelude Inc. Additionally, from 2010 to 2013, they were the Managing Director at Fjord Ventures.

Roy Cosan attended Western Michigan University - Haworth College of Business. However, no information is available regarding the specific years of their enrollment, the degree they pursued, or their field of study.